Franklin Resources Inc Replimune Group, Inc. Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$10.26 - $16.24 $321,168 - $508,360	-31,303 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$9.97 - $15.57 $418,091 - $652,927	-41,935 Reduced 57.26%	31,303 $313,000
Q3 2018 Nov 13, 2018	BUY	$14.99 - $22.14 $1.1 Million - $1.62 Million	73,238 New	73,238 $1.18 Million

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $605M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.